Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

89% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (10)
P 2 (1)

Trial Status

Completed8
Not Yet Recruiting2
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (11)

Research Network

Activity Timeline